US6696561B1
(en)
|
1909-07-09 |
2004-02-24 |
Basf Aktiengesellschaft |
Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
US5030453A
(en)
|
1983-03-24 |
1991-07-09 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
WO1990005144A1
(en)
|
1988-11-11 |
1990-05-17 |
Medical Research Council |
Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
|
WO1990006952A1
(en)
|
1988-12-22 |
1990-06-28 |
Kirin-Amgen, Inc. |
Chemically modified granulocyte colony stimulating factor
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
US6291158B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
US6040138A
(en)
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
US5800992A
(en)
|
1989-06-07 |
1998-09-01 |
Fodor; Stephen P.A. |
Method of detecting nucleic acids
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5763566A
(en)
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue SELEX
|
US6261774B1
(en)
|
1990-06-11 |
2001-07-17 |
Gilead Sciences, Inc. |
Truncation selex method
|
US5712375A
(en)
|
1990-06-11 |
1998-01-27 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US5789157A
(en)
|
1990-06-11 |
1998-08-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US5864026A
(en)
|
1990-06-11 |
1999-01-26 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
DE69123979T2
(de)
|
1990-10-12 |
1997-04-30 |
Max Planck Gesellschaft |
Abgeänderte ribozyme
|
US5840867A
(en)
|
1991-02-21 |
1998-11-24 |
Gilead Sciences, Inc. |
Aptamer analogs specific for biomolecules
|
DE4216134A1
(de)
|
1991-06-20 |
1992-12-24 |
Europ Lab Molekularbiolog |
Synthetische katalytische oligonukleotidstrukturen
|
US5582981A
(en)
|
1991-08-14 |
1996-12-10 |
Gilead Sciences, Inc. |
Method for identifying an oligonucleotide aptamer specific for a target
|
ATE262374T1
(de)
|
1991-11-22 |
2004-04-15 |
Affymetrix Inc |
Kombinatorische strategien für polymersynthese
|
WO1993011236A1
(en)
|
1991-12-02 |
1993-06-10 |
Medical Research Council |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
EP2224006A1
(en)
|
1991-12-02 |
2010-09-01 |
MedImmune Limited |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
US5652094A
(en)
|
1992-01-31 |
1997-07-29 |
University Of Montreal |
Nucleozymes
|
WO1993022332A2
(en)
|
1992-04-24 |
1993-11-11 |
Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5756291A
(en)
|
1992-08-21 |
1998-05-26 |
Gilead Sciences, Inc. |
Aptamers specific for biomolecules and methods of making
|
US6765087B1
(en)
|
1992-08-21 |
2004-07-20 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
DK1589107T3
(da)
|
1992-08-21 |
2010-04-26 |
Univ Bruxelles |
Immonuglobuliner uden lette kæder
|
ATE196606T1
(de)
|
1992-11-13 |
2000-10-15 |
Idec Pharma Corp |
Therapeutische verwendung von chimerischen und markierten antikörpern, die gegen ein differenzierung-antigen gerichtet sind, dessen expression auf menschliche b lymphozyt beschränkt ist, für die behandlung von b-zell-lymphoma
|
EP0714409A1
(en)
|
1993-06-16 |
1996-06-05 |
Celltech Therapeutics Limited |
Antibodies
|
US6448373B1
(en)
|
1994-01-11 |
2002-09-10 |
Isis Pharmaceuticals, Inc. |
Phosphate linked oligomers formed of monomeric diols and processes for preparing same
|
SE9400088D0
(sv)
|
1994-01-14 |
1994-01-14 |
Kabi Pharmacia Ab |
Bacterial receptor structures
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
US5556752A
(en)
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
US5716824A
(en)
|
1995-04-20 |
1998-02-10 |
Ribozyme Pharmaceuticals, Inc. |
2'-O-alkylthioalkyl and 2-C-alkylthioalkyl-containing enzymatic nucleic acids (ribozymes)
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
EP0823914B1
(en)
|
1995-05-03 |
2004-08-25 |
Gilead Sciences, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US6013443A
(en)
|
1995-05-03 |
2000-01-11 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue SELEX
|
US6111095A
(en)
|
1995-06-07 |
2000-08-29 |
Merck & Co., Inc. |
Capped synthetic RNA, analogs, and aptamers
|
US5545531A
(en)
|
1995-06-07 |
1996-08-13 |
Affymax Technologies N.V. |
Methods for making a device for concurrently processing multiple biological chip assays
|
US5854033A
(en)
|
1995-11-21 |
1998-12-29 |
Yale University |
Rolling circle replication reporter systems
|
CA2253382A1
(en)
|
1996-01-16 |
1997-07-24 |
Ribozyme Pharmaceuticals, Inc. |
Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
|
EP0880598A4
(en)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
|
US5792613A
(en)
|
1996-06-12 |
1998-08-11 |
The Curators Of The University Of Missouri |
Method for obtaining RNA aptamers based on shape selection
|
US5849902A
(en)
|
1996-09-26 |
1998-12-15 |
Oligos Etc. Inc. |
Three component chimeric antisense oligonucleotides
|
US6977244B2
(en)
|
1996-10-04 |
2005-12-20 |
Board Of Regents, The University Of Texas Systems |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
|
US6617114B1
(en)
|
1996-10-31 |
2003-09-09 |
Karo Bio Ab |
Identification of drug complementary combinatorial libraries
|
US6295514B1
(en)
|
1996-11-04 |
2001-09-25 |
3-Dimensional Pharmaceuticals, Inc. |
Method, system, and computer program product for representing similarity/dissimilarity between chemical compounds
|
DE19649359C1
(de)
|
1996-11-28 |
1998-02-12 |
Thomas Prof Dr Peters |
Verfahren zum Nachweis biologisch aktiver Substanzen in Substanzbibliotheken
|
PT971946E
(pt)
|
1997-01-21 |
2006-11-30 |
Gen Hospital Corp |
Selecção de proteínas utilizando fusões arn-proteína
|
US6261804B1
(en)
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US5891467A
(en)
|
1997-01-31 |
1999-04-06 |
Depotech Corporation |
Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
TR199902800T2
(xx)
|
1997-05-15 |
2000-04-21 |
Chugai Seiyaku Kabushiki Kaisha |
Ka�eksiyi tedavi edici madde.
|
CA2290485C
(en)
|
1997-05-21 |
2008-08-05 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
AR013269A1
(es)
|
1997-08-04 |
2000-12-13 |
Scras |
Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
|
DE19742706B4
(de)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
Lipocalinmuteine
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
DE69829402T2
(de)
|
1997-10-31 |
2006-04-13 |
Affymetrix, Inc. (a Delaware Corp.), Santa Clara |
Expressionsprofile in adulten und fötalen organen
|
WO1999031276A1
(en)
|
1997-12-15 |
1999-06-24 |
Nexstar Pharmaceuticals, Inc. |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
SK287538B6
(sk)
|
1998-03-20 |
2011-01-04 |
Commonwealth Scientific And Industrial Research Organisation |
Syntetický gén obsahujúci dispergovanú alebo cudzorodú deoxyribonukleovú molekulu, génový konštrukt obsahujúci tento syntetický gén a prípravok obsahujúci tento syntetický gén
|
US6020135A
(en)
|
1998-03-27 |
2000-02-01 |
Affymetrix, Inc. |
P53-regulated genes
|
US6054047A
(en)
|
1998-03-27 |
2000-04-25 |
Synsorb Biotech, Inc. |
Apparatus for screening compound libraries
|
CA2240325A1
(en)
|
1998-03-27 |
1998-11-14 |
Synsorb Biotech, Inc. |
Methods for screening compound libraries
|
US6613575B1
(en)
|
1998-03-27 |
2003-09-02 |
Ole Hindsgaul |
Methods for screening compound libraries
|
US6720190B1
(en)
|
1998-03-27 |
2004-04-13 |
Ole Hindsgaul |
Methods for screening compound libraries
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
WO1999051773A1
(en)
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Addressable protein arrays
|
WO1999053050A1
(en)
|
1998-04-08 |
1999-10-21 |
Commonwealth Scientific And Industrial Research Organisation |
Methods and means for obtaining modified phenotypes
|
WO1999054342A1
(en)
|
1998-04-20 |
1999-10-28 |
Pablo Umana |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
US6458559B1
(en)
|
1998-04-22 |
2002-10-01 |
Cornell Research Foundation, Inc. |
Multivalent RNA aptamers and their expression in multicellular organisms
|
US6846655B1
(en)
|
1998-06-29 |
2005-01-25 |
Phylos, Inc. |
Methods for generating highly diverse libraries
|
GB9827152D0
(en)
|
1998-07-03 |
1999-02-03 |
Devgen Nv |
Characterisation of gene function using double stranded rna inhibition
|
EP1105516A4
(en)
|
1998-08-17 |
2002-01-09 |
Phylos Inc |
METHODS FOR PRODUCING PRIVATE NUCLEIC ACIDS FROM 3 'NON-TRANSLATED REGIONS AND FOR OPTIMIZING THE FORMATION OF A CELL-PROTEIN RNA FUSION
|
AU757955B2
(en)
|
1998-08-17 |
2003-03-13 |
Bristol-Myers Squibb Company |
Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
|
US6194402B1
(en)
|
1998-09-02 |
2001-02-27 |
Merck & Co., Inc. |
Enhancement of return to independent living status with a growth hormone secretagogue
|
EP1121111B1
(en)
|
1998-10-15 |
2010-02-10 |
Imperial Innovations Limited |
Compounds for the treatment of weight loss
|
AU1611900A
(en)
|
1998-11-09 |
2000-05-29 |
Chemrx Advanced Technologies, Inc. |
Process for the synthesis of quinazolinones
|
ES2280131T3
(es)
|
1998-12-02 |
2007-09-01 |
Adnexus Therapeutics, Inc. |
Fusiones de adn-proteina y utilizaciones de las mismas.
|
US7115396B2
(en)
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
US6818418B1
(en)
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
PL209786B1
(pl)
|
1999-01-15 |
2011-10-31 |
Genentech Inc |
Przeciwciało zawierające wariant regionu Fc ludzkiej IgG1, przeciwciało wiążące czynnik wzrostu śródbłonka naczyń oraz immunoadhezyna
|
EP1147204A1
(en)
|
1999-01-28 |
2001-10-24 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
ES2420835T3
(es)
|
1999-04-09 |
2013-08-27 |
Kyowa Hakko Kirin Co., Ltd. |
Procedimiento para controlar la actividad de las moléculas inmunofuncionales
|
KR20070118315A
(ko)
|
1999-04-21 |
2007-12-14 |
와이어쓰 |
폴리뉴클레오티드 서열의 기능을 억제하기 위한 조성물
|
JP2003500081A
(ja)
|
1999-06-01 |
2003-01-07 |
フィロス インク. |
5’核酸−タンパク質結合体の生成法
|
MXPA01013462A
(es)
|
1999-07-09 |
2002-07-02 |
Wyeth Corp |
Metodos y composiciones para prevenir la formacion de arn aberrante durante la transcripcion de una secuencia plasmidica.
|
AU778194B2
(en)
|
1999-07-12 |
2004-11-18 |
Bristol-Myers Squibb Company |
C-terminal protein tagging
|
PT1196637E
(pt)
|
1999-07-27 |
2007-07-04 |
Adnexus Therapeutics Inc |
Métodos de ligação de aceitadores de péptidos.
|
US6387620B1
(en)
|
1999-07-28 |
2002-05-14 |
Gilead Sciences, Inc. |
Transcription-free selex
|
WO2001016352A1
(en)
|
1999-08-27 |
2001-03-08 |
Phylos, Inc. |
Methods for encoding and sorting in vitro translated proteins
|
US20030044846A1
(en)
|
2001-04-03 |
2003-03-06 |
Gary Eldridge |
Screening of chemical compounds purified from biological sources
|
US6677160B1
(en)
|
1999-09-29 |
2004-01-13 |
Pharmacia & Upjohn Company |
Methods for creating a compound library and identifying lead chemical templates and ligands for target molecules
|
US6764858B2
(en)
|
1999-09-29 |
2004-07-20 |
Pharmacia & Upjohn Company |
Methods for creating a compound library
|
EP1235842A4
(en)
|
1999-10-15 |
2003-04-23 |
Univ Massachusetts |
GENESIS OF THE RNA INTERFERENCE PATH AS AID OF TARGETED GENTIAN INTERFERENCE
|
GB9927444D0
(en)
|
1999-11-19 |
2000-01-19 |
Cancer Res Campaign Tech |
Inhibiting gene expression
|
DE10160151A1
(de)
|
2001-01-09 |
2003-06-26 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines vorgegebenen Zielgens
|
DE10100586C1
(de)
|
2001-01-09 |
2002-04-11 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines Ziegens
|
WO2001038551A1
(en)
|
1999-11-29 |
2001-05-31 |
Cold Spring Harbor Laboratory |
Regulation of polycomb group gene expression for increasing seed size in plants
|
RU2164944C1
(ru)
|
1999-12-09 |
2001-04-10 |
Институт молекулярной биологии им. В.А. Энгельгардта РАН |
Способ изменения генетических свойств организма
|
AU2625501A
(en)
|
1999-12-30 |
2001-07-16 |
Rutgers, The State University Of New Jersey |
Compositions and methods for gene silencing
|
IT1316982B1
(it)
|
2000-01-17 |
2003-05-26 |
Univ Roma |
Isolamento e caratterizzazione di un gene per il silenziamento genicoda n.crassa e suoi usi.
|
CN1319761A
(zh)
|
2000-03-15 |
2001-10-31 |
清华大学 |
高通量电旋转检测的装置和方法
|
EP1266218A2
(en)
|
2000-03-15 |
2002-12-18 |
Aviva Biosciences Corporation |
Apparatus and method for high throughput electrorotation analysis
|
EP1272630A2
(en)
|
2000-03-16 |
2003-01-08 |
Genetica, Inc. |
Methods and compositions for rna interference
|
JP2003527856A
(ja)
|
2000-03-17 |
2003-09-24 |
ベニテック オーストラリア リミテッド |
遺伝子のサイレンシング
|
AU2001260140A1
(en)
|
2000-03-22 |
2001-10-03 |
Avntis Pharma Deutschland Gmbh |
Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene.
|
GB0007268D0
(en)
|
2000-03-24 |
2000-05-17 |
Cyclacel Ltd |
Cell cycle progression proteins
|
KR20080023768A
(ko)
|
2000-03-30 |
2008-03-14 |
화이트헤드 인스티튜트 포 바이오메디칼 리서치 |
Rna 간섭의 rna 서열 특이적인 매개체
|
CA2441903C
(en)
|
2000-05-26 |
2012-07-31 |
National Research Council Of Canada |
Single-domain brain-targeting antibody fragments derived from llama antibodies
|
JP4901051B2
(ja)
|
2000-05-30 |
2012-03-21 |
ジョンソン アンド ジョンソン リサーチ プロプライアトリー リミテッド |
RNAiを増強する因子を使用することによって遺伝子抑制を媒介する方法
|
IL143942A0
(en)
|
2000-06-29 |
2002-04-21 |
Pfizer Prod Inc |
Use of growth hormone secretagogues for treatment of physical performance decline
|
US6680068B2
(en)
|
2000-07-06 |
2004-01-20 |
The General Hospital Corporation |
Drug delivery formulations and targeting
|
AU2002218166A1
(en)
|
2000-09-08 |
2002-03-22 |
Universitat Zurich |
Collections of repeat proteins comprising repeat modules
|
AU2002224838B9
(en)
|
2000-11-09 |
2007-02-08 |
Cenix Bioscience Gmbh |
Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
|
CZ302719B6
(cs)
|
2000-12-01 |
2011-09-21 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Izolovaná molekula dvouretezcové RNA, zpusob její výroby a její použití
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
IL158419A0
(en)
|
2001-04-19 |
2004-05-12 |
Scripps Research Inst |
Methods and composition for the production of orthoganal trna-aminoacyl trna synthetase pairs
|
CA2444854A1
(en)
|
2001-04-26 |
2002-11-07 |
Avidia Research Institute |
Combinatorial libraries of monomer domains
|
US20050048512A1
(en)
|
2001-04-26 |
2005-03-03 |
Avidia Research Institute |
Combinatorial libraries of monomer domains
|
US20060223114A1
(en)
|
2001-04-26 |
2006-10-05 |
Avidia Research Institute |
Protein scaffolds and uses thereof
|
US20050053973A1
(en)
|
2001-04-26 |
2005-03-10 |
Avidia Research Institute |
Novel proteins with targeted binding
|
US20040175756A1
(en)
|
2001-04-26 |
2004-09-09 |
Avidia Research Institute |
Methods for using combinatorial libraries of monomer domains
|
US20050089932A1
(en)
|
2001-04-26 |
2005-04-28 |
Avidia Research Institute |
Novel proteins with targeted binding
|
US20030157561A1
(en)
|
2001-11-19 |
2003-08-21 |
Kolkman Joost A. |
Combinatorial libraries of monomer domains
|
WO2002100435A1
(en)
|
2001-06-11 |
2002-12-19 |
Centre Hospitalier Universitaire De Montreal |
Compositions and methods for enhancing nucleic acid transfer into cells
|
AU2002310502A1
(en)
|
2001-06-21 |
2003-01-08 |
Phylos, Inc. |
In vitro protein interaction detection systems
|
DE60237282D1
(de)
|
2001-06-28 |
2010-09-23 |
Domantis Ltd |
Doppelspezifischer ligand und dessen verwendung
|
FR2827518B1
(fr)
|
2001-07-17 |
2005-07-08 |
Sod Conseils Rech Applic |
Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
|
EP1419274A4
(en)
|
2001-07-31 |
2006-02-08 |
Phylos Inc |
MODULAR CONSTRUCTION OF NUCLEIC ACID PROTEIN FUSION MULTIMERS
|
FR2828208A1
(fr)
*
|
2001-08-01 |
2003-02-07 |
Cytomics Systems |
Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie
|
JP5170934B2
(ja)
|
2001-08-16 |
2013-03-27 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
改良dnaリポフェクションならびに/または徐放性プロドラッグおよび薬物療法のための試薬の合成と使用
|
MXPA04003798A
(es)
|
2001-10-25 |
2004-07-30 |
Genentech Inc |
Composiciones de glicoproteina.
|
WO2003045975A2
(en)
|
2001-11-27 |
2003-06-05 |
Compound Therapeutics, Inc. |
Solid-phase immobilization of proteins and peptides
|
EP2221377B2
(en)
|
2002-02-01 |
2017-05-17 |
Life Technologies Corporation |
Oligonucleotide compositions with enhanced efficiency
|
US6936427B2
(en)
|
2002-02-08 |
2005-08-30 |
Trellis Bioscience, Inc. |
Real time detection of intermolecular interaction
|
EP1517921B1
(en)
|
2002-06-28 |
2006-06-07 |
Domantis Limited |
Dual specific ligands with increased serum half-life
|
DE60334618D1
(de)
|
2002-06-28 |
2010-12-02 |
Protiva Biotherapeutics Inc |
Verfahren und vorrichtung zur herstellung von liposomen
|
CA2500468A1
(en)
|
2002-09-28 |
2004-04-08 |
Massachussets Institute Of Technology |
Influenza therapeutic
|
AU2003275372A1
(en)
|
2002-09-30 |
2004-04-19 |
Compound Therapeutics, Inc. |
Methods of engineering spatially conserved motifs in polypeptides
|
EP2267032A3
(en)
|
2002-11-08 |
2011-11-09 |
Ablynx N.V. |
Method of administering therapeutic polypeptides, and polypeptides therefor
|
EP1585756B1
(en)
|
2002-11-26 |
2010-04-21 |
University of Massachusetts |
Delivery of sirnas
|
US7288570B2
(en)
|
2002-12-20 |
2007-10-30 |
Nutricia N.V. |
Stimulation of in vivo production of proteins
|
AU2003290330A1
(en)
|
2002-12-27 |
2004-07-22 |
Domantis Limited |
Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
|
US20040208921A1
(en)
|
2003-01-14 |
2004-10-21 |
Ho Rodney J. Y. |
Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymphoid tissues
|
EP1627062A1
(en)
|
2003-05-14 |
2006-02-22 |
Domantis Limited |
A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
|
ES2315664T3
(es)
|
2003-06-30 |
2009-04-01 |
Domantis Limited |
Anticuerpos de dominio unico (dab) pegilados.
|
AU2004269150C1
(en)
|
2003-08-28 |
2010-11-18 |
Novartis Ag |
Interfering RNA duplex having blunt-ends and 3'-modifications
|
US20050164301A1
(en)
|
2003-10-24 |
2005-07-28 |
Avidia Research Institute |
LDL receptor class A and EGF domain monomers and multimers
|
CA2554218A1
(en)
|
2004-02-05 |
2005-08-18 |
Novartis Ag |
Screening assays
|
US20060008844A1
(en)
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
AU2005307789A1
(en)
|
2004-11-16 |
2006-05-26 |
Avidia Research Institute |
Protein scaffolds and uses thereof
|
US7429482B2
(en)
*
|
2005-01-13 |
2008-09-30 |
United States Of America As Represented By The Department Of Veterans Affairs |
Screening tools for discovery of novel anabolic agents
|
CA2595682A1
(en)
|
2005-01-31 |
2006-08-03 |
Ablynx N.V. |
Method for generating variable domain sequences of heavy chain antibodies
|
US20070191272A1
(en)
|
2005-09-27 |
2007-08-16 |
Stemmer Willem P |
Proteinaceous pharmaceuticals and uses thereof
|
BRPI0619056A2
(pt)
|
2005-11-28 |
2011-09-20 |
Genmab As |
anticorpo monovalente, método para preparar e produzir um antcorpo monovalente, construção de ácido nucleico, célula hospedeira, imunoconjugado, uso de um anticorpo monovalente, e, composição farmacêutica
|
CA2631647A1
(en)
|
2005-11-30 |
2007-06-07 |
Nestec S.A. |
Use of branched-chain amino acids for the treatment of muscle loss
|
US7442706B2
(en)
|
2006-03-15 |
2008-10-28 |
Thorner Michael O |
Methods for treating sarcopenia with a growth hormone secretagogue
|
GB0608838D0
(en)
|
2006-05-04 |
2006-06-14 |
Novartis Ag |
Organic compounds
|
US8240498B2
(en)
|
2006-10-31 |
2012-08-14 |
Crown Packaging Technology, Inc. |
Resealable closure
|
US20080108145A1
(en)
*
|
2006-11-07 |
2008-05-08 |
Stephanie Chissoe |
Genes associated with osteoarthritis
|
US20100291551A1
(en)
*
|
2006-11-17 |
2010-11-18 |
Genizon Biosciences Inc. |
Genemap of the human associated with crohn's disease
|
CN101616934A
(zh)
*
|
2006-12-22 |
2009-12-30 |
健泰科生物技术公司 |
抑制dr6结合app的dr6抗体及其在治疗神经学病症中的用途
|
JP6776582B2
(ja)
|
2016-03-31 |
2020-10-28 |
Tdk株式会社 |
電子部品
|
US11054998B1
(en)
|
2019-12-12 |
2021-07-06 |
Facebook, Inc. |
High bandwidth memory system with distributed request broadcasting masters
|